基本信息来源于合作网站,原文需代理用户跳转至来源网站获取       
摘要:
AIM To describe trends of combination therapy(CT)of infliximab(IFX)and immunomodulator(IMM)for inflammatory bowel disease(IBD)in the community setting.METHODS A retrospective study was conducted of all IBD patients referred for IFX infusion to our community infusion center between 04/01/01 and 12/31/14.CT was defined as use of IFX with either azathioprine,6-mercaptopurine,or methotrexate.We analyzed trends of CT usage overall,for Crohn’s disease(CD)and ulcerative colitis(UC),and for the subgroups of induction patients.We also analyzed the trends of CT use in these groups over the study period,and compared the rates of CT use prior to and after publication of the landmark SONIC trial.RESULTS Of 258 IBD patients identified during the 12 year study period,60(23.3%)received CT,including 35 of 133(26.3%)induction patients.Based on the Cochran-Armitage trend test,we observed decreasing CT use for IBD patients overall(p<0.0001)and IBD induction patients,(p=0.0024).Of 154 CD patients,37(24.68%)had CT,including 20 of 77(26%)induction patients.The Cochran Armitage test showed a trend towards decreasing CT use for CD overall(p<0.0001)and CD induction,(p=0.0024).Overall,43.8%of CD patients received CT pre-SONIC vs 7.4%post-SONIC(p<0.0001).For CD induction,40.0%received CT pre-SONIC vs 10.8%post-SONIC(p=0.0035).Among the 93 patients with UC,19(20.4%)received CT.Of 50 induction patients,14(28.0%)received CT.The trend test of the 49 patients with a known year of induction again failed to demonstrate any significant trends in the use of CT(p=0.6).CONCLUSION We observed a trend away from CT use in IBD.A disconnect appears to exist between expert opinion and evidence favoring CT with IFX and IMM,and evolving community practice.
推荐文章
单克隆抗体Infliximab治疗克罗恩病研究进展
克罗恩病
单克隆抗体
infliximab
炎症性肠病手术切除标本临床病理特征及鉴别诊断
炎症性肠病
溃疡性结肠炎
克罗恩病
Infliximab对急性坏死性胰腺炎并MODS模型大鼠肝损害的防治
急性坏死性胰腺炎
多器官功能障碍
肝损害
肿瘤坏死因子-α(TNF-α)
英夫利昔单抗
奥曲肽
炎性肠病与家庭饮食
炎性肠病
家庭饮食
相关性
内容分析
关键词云
关键词热度
相关文献总数  
(/次)
(/年)
文献信息
篇名 Declining use of combination infliximab and immunomodulator for inflammatory bowel disease in the community setting
来源期刊 世界胃肠药理与治疗学杂志:英文版(电子版) 学科 医学
关键词 Crohn’s DISEASE ULCERATIVE colitis INFLIXIMAB AZATHIOPRINE Inflammatory bowel DISEASE
年,卷(期) 2018,(1) 所属期刊栏目
研究方向 页码范围 8-13
页数 6页 分类号 R
字数 语种
DOI
五维指标
传播情况
(/次)
(/年)
引文网络
引文网络
二级参考文献  (0)
共引文献  (0)
参考文献  (0)
节点文献
引证文献  (0)
同被引文献  (0)
二级引证文献  (0)
2018(0)
  • 参考文献(0)
  • 二级参考文献(0)
  • 引证文献(0)
  • 二级引证文献(0)
研究主题发展历程
节点文献
Crohn’s
DISEASE
ULCERATIVE
colitis
INFLIXIMAB
AZATHIOPRINE
Inflammatory
bowel
DISEASE
研究起点
研究来源
研究分支
研究去脉
引文网络交叉学科
相关学者/机构
期刊影响力
世界胃肠药理与治疗学杂志:英文版(电子版)
双月刊
2150-5349
北京市朝阳区东四环中路62号楼远洋国际中
出版文献量(篇)
323
总下载数(次)
0
总被引数(次)
0
  • 期刊分类
  • 期刊(年)
  • 期刊(期)
  • 期刊推荐
论文1v1指导